Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (27 ops.)
Latest filing published 07 Dec 2015 for Midatech Pharma US Inc..
Insider track record
Disclosed buys
1
Disclosed sells
27
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Christopher G. Clement: trading record in brief
This profile gathers the share dealings of Christopher G. Clement across 2 companies, led by Savient Pharmaceuticals Inc and Midatech Pharma US Inc. The record holds 51 filings, for trades running from 15 February 2006 to 4 December 2015.
In open-market terms, that means 1 purchase worth €7,631 on one side and 27 sales worth €2.0M on the other. The net balance comes to €2.0M on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 11 share grants and 11 option exercises.
The newest entry dates from 7 December 2015: a transaction, in Midatech Pharma US Inc. The most recent open-market purchase was published on 4 June 2013, 4,890 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Christopher G. Clement
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations46 total
54,558 sharesCommon StockSEC:0001354488-15-005391:0
14,000 shares@ US$0.7126Common StockSEC:0001354488-13-003303:0
Canonical exit: 1 Sept 2013 (T+90)
43,133 sharesCommon StockSEC:0001181431-12-033412:0
215,661 sharesCommon StockSEC:0001181431-12-003072:0
21,666 shares@ US$4.53Common Stock, $0.1 par value per shareSEC:0000950117-08-001525:0
9,225 shares@ US$4.79Common Stock, $0.1 par value per shareSEC:0000950117-08-001525:1
200 shares@ US$4.81Common Stock, $0.1 par value per shareSEC:0000950117-08-001525:2
32,500 shares@ US$5.17Common Stock, $0.1 par value per shareSEC:0000950117-08-001330:0
14,762 shares@ US$5.17Common Stock, $0.1 par value per shareSEC:0000950117-08-001330:1
7,570 shares@ US$19.06Common Stock, $.01 par value per shareSEC:0001230295-08-000246:0
25,000 shares@ US$23.01Common Stock, $.01 par value per shareSEC:0001230295-08-000175:0
11,355 shares@ US$23.42Common Stock, $.01 par value per shareSEC:0001230295-08-000175:1
5,903 shares@ US$20.00Common Stock, $.01 par value per shareSEC:0001230295-08-000134:0
5,209 shares@ US$20.00Common Stock, $.01 par value per shareSEC:0001230295-08-000134:1
3,000 shares@ US$2.78Common Stock, $.01 par value per shareSEC:0001230295-08-000047:0
3,000 shares@ US$21.35Common Stock, $.01 par value per shareSEC:0001230295-08-000047:1
2,000 shares@ US$2.97Common Stock, $.01 par value per shareSEC:0001230295-08-000047:2
2,000 shares@ US$21.37Common Stock, $.01 par value per shareSEC:0001230295-08-000047:3
5,000 shares@ US$2.97Common Stock, $.01 par value per shareSEC:0001230295-08-000047:4
5,000 shares@ US$21.24Common Stock, $.01 par value per shareSEC:0001230295-08-000047:5
5,000 shares@ US$2.97Common Stock, $.01 par value per shareSEC:0001230295-08-000047:6
5,000 shares@ US$20.29Common Stock, $.01 par value per shareSEC:0001230295-08-000047:7
3,000 shares@ US$23.21Common Stock, $.01 par value per shareSEC:0001230295-08-000048:1
5,000 shares@ US$2.78Common Stock, $.01 par value per shareSEC:0001230295-08-000031:0
5,000 shares@ US$22.42Common Stock, $.01 par value per shareSEC:0001230295-08-000031:1
25 of 46 declarations
